Wen-Wen Chou

Title: Innovations by Wen-Wen Chou in Hepatitis C Research

Introduction

Wen-Wen Chou is a notable inventor based in Kaohsiung, Taiwan. She has made significant contributions to the field of medical research, particularly in the study of hepatitis C virus. Her innovative approach has led to the development of a method that evaluates the therapeutic efficacy of treatments for this viral infection.

Latest Patents

Wen-Wen Chou holds 1 patent related to her research. The patent is titled "Use of Let-7g to down regulate NS5B gene, core protein and viral load of hepatitis C virus." This method involves providing a specimen, mixing it with a primer of the miRNA Let-7g and a PCR reagent, and evaluating the efficacy of interferon (IFN) and ribavirin (RBV) on inhibiting the hepatitis C virus. The evaluation is based on the expression level of the miRNA Let-7g detected by the PCR reagent.

Career Highlights

Wen-Wen Chou is affiliated with Kaohsiung Medical University, where she conducts her research. Her work has been instrumental in advancing the understanding of hepatitis C and improving treatment methodologies.

Collaborations

Wen-Wen collaborates with esteemed colleagues, including Chia-Yen Dai and Ming-Lung Yu. Their combined efforts contribute to the ongoing research and development in the field of virology.

Conclusion

Wen-Wen Chou's innovative research and patent in hepatitis C treatment exemplify her commitment to advancing medical science. Her contributions are vital in the fight against viral infections, showcasing the importance of innovation in healthcare.